Pharming Group N.V. (PHAR)

Pharming Group Stock Forecast

Stock Price Forecast

The 3 analysts that cover Pharming Group stock have a consensus rating of "Strong Buy" and an average price target of $38.33, which forecasts a 194.85% increase in the stock price over the next year. The lowest target is $37 and the highest is $41.

Price Target: $38.33 (+194.85%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$37	$38.33	$37	$41
Change	+184.62%	+194.85%	+184.62%	+215.38%

* Price targets were last updated on Apr 10, 2026.

Analyst Ratings

The average analyst rating for Pharming Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	1	2	2
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	2	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Strong Buy Initiates $37	Strong Buy	Initiates	$37	+184.62%	Apr 10, 2026
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $37	Strong Buy	Reiterates	$37	+184.62%	Mar 24, 2026
Jeff Jones Oppenheimer	Oppenheimer	Buy Reiterates $42 → $41	Buy	Reiterates	$42 → $41	+215.38%	Mar 13, 2026
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $37	Strong Buy	Reiterates	$37	+184.62%	Mar 21, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $37	Strong Buy	Reiterates	$37	+184.62%	Mar 20, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

434.02M

Increased by 15.39%

from 376.13M

Revenue Next Year

455.05M

Increased by 4.85%

from 434.02M

EPS This Year

0.03

Increased by 743.52%

from 0.00

EPS Next Year

0.04

Increased by 28.24%

from 0.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	198.87M	205.62M	245.32M	297.20M	376.13M	434.02M	455.05M
Revenue Growth	-6.27%	3.40%	19.30%	21.15%	26.56%	15.39%	4.85%
EPS	0.02	0.02	-0.02	-0.02	0.00	0.03	0.04
EPS Growth	-58.18%	-17.39%	-	-	-	743.52%	28.24%
Forward PE	-	-	-	-	-	385.39	300.51
No. Analysts	-	-	-	-	-	9	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	477.0M	557.8M
Avg	434.0M	455.1M
Low	391.0M	385.9M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	26.8%	28.5%
Avg	15.4%	4.8%
Low	4.0%	-11.1%

EPS Forecast

EPS	2026	2027	2028	2029
High	0.05	0.09
Avg	0.03	0.04
Low	0.01	-0.01

EPS Growth

EPS Growth	2026	2027	2028	2029
High	1,265.3%	155.2%
Avg	743.5%	28.2%
Low	145.1%	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.